Cleared Traditional

K090630 - NOBEL BIOCARE ENDOSSEOUS IMPLANTS (MAXILLOFACIAL INDICATION) (FDA 510(k) Clearance)

Jun 2009
Decision
85d
Days
Class 2
Risk

K090630 is an FDA 510(k) clearance for the NOBEL BIOCARE ENDOSSEOUS IMPLANTS (MAXILLOFACIAL INDICATION). This device is classified as a Prosthesis, Nose, Internal (Class II - Special Controls, product code FZE).

Submitted by Nobel Biocare AB (Yorba Linda,, US). The FDA issued a Cleared decision on June 2, 2009, 85 days after receiving the submission on March 9, 2009.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.3680.

Submission Details

510(k) Number K090630 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 09, 2009
Decision Date June 02, 2009
Days to Decision 85 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FZE — Prosthesis, Nose, Internal
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3680